JOANNA VAN DOREN: Open Payments
NPI 1700235868 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,142 in 185 payments from 19 companies in 2025. Trend: 2023 $1,233 · 2024 $2,376 · 2025 $3,142
Food & beverage: $3,099Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 64 | $519 |
| Janssen Biotech, Inc. | 21 | $515 |
| Novartis Pharmaceuticals Corporation | 16 | $409 |
| UCB, Inc. | 12 | $369 |
| Regeneron Healthcare Solutions, Inc. | 18 | $319 |
| Botanix SB Inc | 5 | $166 |
| Galderma Laboratories, L.P. | 13 | $164 |
| Amgen Inc. | 4 | $144 |
| GENZYME CORPORATION | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, SOFDRA, Otezla, COSENTYX.
Industry payments across MA — which companies pay providers there.
